Moderna and Thermo Fisher grow as life science industry continues to thrive

Maddie Meyer / Getty Images

The COVID-19 pandemic has not hit the life sciences industry as hard as other sectors of the economy, as evidenced by recent announcements of new manufacturing sites, headquarters and additional staff. Here is a preview.

Moderna invests in New Cambridge, Mass. Science center

Moderna To selected longtime partner Alexandria Real Estate Equities to develop, construct and operate a new head office at the Alexandria Center on the One Kendall Square campus in Cambridge, Mass. It will measure 462,000 square feet and will be the Moderna Science Center. The company said, “The new site will include customized spaces for cutting-edge research and development. The building will integrate scientific and non-scientific spaces to maximize collaboration and bring about breakthrough innovation.

Construction has already started and they expect to be able to start moving in in 2023.

“We have been located in Massachusetts since our founding over 10 years ago and are proud to be based here,” said Stéphane Bancel, CEO of Moderna. “As we advance our mRNA platform and science, our new science center will integrate digitally-focused scientific research and development labs as well as a space for innovation and co- creation with our employees and partners around the world. ”

Expansion of Thermo Fisher Scientific in Saint-Louis and Switzerland

Thermo Fisher Scientific announcement plans to invest $ 82.5 million in its biologic drug manufacturing site in St. Louis County, Missouri. It plans to create 169 new jobs.

“This new expansion will allow further innovation in the manufacturing of biologics to meet the continued growth of important therapies and drugs,” said Michel Lagarde, executive vice president of Thermo Fisher Scientific. “We look forward to our continued contribution to job creation and economic development in this region.

The company based in Waltham, Mass. also have announcement she took on operational responsibility for a new biological products manufacturing plant in Lengnau, Switzerland. This is part of its strategic partnership with CSL Limited announcement in 2020. The location will be part of the company’s global organic manufacturing network. Approximately 200 employees will join Thermo Fisher. The location has 1.5 million square feet of space and features highly flexible bioproduction technology, including single-use and stainless steel capacities with a bioreactor capacity of up to 12,500 L.

“We are delighted to add the new Lengnau site to our global biologics manufacturing network and we are delighted to welcome over 200 new colleagues to Thermo Fisher,” said Lagarde. “Through our partnership with CSL, this site further strengthens our unique customer value proposition to leverage our scale and depth of capabilities for pharmaceutical and biotech customers. “

Sartorius Expands Presence in Michigan

Aubagne, based in France Sartorius is expansion in Michigan, with plans to open a new 130,000 square foot plant in Ann Arbor. It will “have an anchor presence” in the technical loop of the Ann Arbor Research Park and add a flagship location in North America. She acquired over 15 acres of land. They plan to create 160 jobs over three years.

“The new facility will consolidate existing business operations in Washtenaw County to create a center of excellence in Ann Arbor for laboratory and bioprocess products and services in North America, which focus on providing innovative solutions to help customers to develop drugs that cure, prevent and halt the progression of disease, ”said Mary Lavin, president of Sartorius North America.

About Shirley Hudson

Check Also

Avani appoints general managers in Thailand

As Thailand’s borders reopen, Avani welcomes new, familiar faces to lead the brand’s portfolio in …

Leave a Reply

Your email address will not be published. Required fields are marked *